Skip to main content
Log in

Four Variants of SLCO2A1 Identified in Three Chinese Patients with Chronic Enteropathy Associated with the SLCO2A1 Gene

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Chronic enteropathy associated with the SLCO2A1 gene (CEAS) is an enteropathy characterized by multiple small intestinal ulcers of nonspecific histology, also known as chronic nonspecific multiple ulcers of the small intestine. The SLCO2A1 gene encodes a prostaglandin transporter (PGT).

Aims

The aim of this study was to investigate the clinical characteristics of ten Chinese patients with intestinal ulcers of unknown origin, screen them for variants of SLCO2A1, and to investigate the expression of PGT in the small intestinal mucosa of patients with CEAS.

Methods

Ten Chinese patients with intestinal ulcers of unknown origin were included in this study. Blood samples were collected for whole-exome sequencing and Sanger sequencing of candidate gene variants. Immunohistochemical staining was used to investigate the expression of PGT.

Results

These ten patients were clinically diagnosed with intestinal ulcers of unknown origin based on criteria established according to earlier publications. Three of them were genetically diagnosed as having CEAS and four candidate variants of the SLCO2A1 gene were identified, among which c.941-1G>A, c.178G>A and c.1681C>T were detected in patients with CEAS for the first time. The terminal ileum was involved in all three patients with CEAS in our study, which was different from the results of Japanese patients. The expression of PGT in the vascular endothelial cells of the intestinal mucosa tissues of patients with CEAS was negative or intermediate.

Conclusion

We summarized the clinical data of ten Chinese patients with intestinal ulcers of unknown origin and identified three novel SLCO2A1 variants from three patients with CEAS. This study improves our understanding of CEAS and broadens the spectrum of SLCO2A1 variants known to cause CEAS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mazal J. Crohn disease: pathophysiology, diagnosis, and treatment. Radiol. Technol.. 2014;85:297–316.

    PubMed  Google Scholar 

  2. Tsibouris P, Kalantzis C, Apostolopoulos P et al. Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding. World J. Gastrointest. Endosc.. 2014;6:612–619. https://doi.org/10.4253/wjge.v6.i12.612.

    Article  Google Scholar 

  3. Wilson IR, Cooley NV, Luibel FJ. Nonspecific stenosing small bowel ulcers. Experience in one California county. Am. J. Gastroenterol.. 1968;50:449–455.

    CAS  PubMed  Google Scholar 

  4. Matsumoto T, Nakamura S, Esaki M et al. Endoscopic features of chronic nonspecific multiple ulcers of the small intestine: comparison with nonsteroidal anti-inflammatory drug-induced enteropathy. Dig. Dis. Sci.. 2006;51:1357–1363. https://doi.org/10.1007/s10620-006-9080-x.

    Article  PubMed  Google Scholar 

  5. Adler DH, Cogan JD, Phillips JA et al. Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J. Clin. Investig.. 2008;118:2121–2131. https://doi.org/10.1172/jci30473.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Esaki M, Umeno J, Kitazono T, Matsumoto T. Clinicopathologic features of chronic nonspecific multiple ulcers of the small intestine. Clin. J. Gastroenterol.. 2015;8:57–62. https://doi.org/10.1007/s12328-015-0559-x.

    Article  PubMed  Google Scholar 

  7. Umeno J, Hisamatsu T, Esaki M et al. A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter. PLoS Genet. 2015;11:e1005581. https://doi.org/10.1371/journal.pgen.1005581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, Schuster VL. Identification and characterization of a prostaglandin transporter. Science. 1995;268:866–869.

    Article  CAS  Google Scholar 

  9. Seifert W, Kuhnisch J, Tuysuz B, Specker C, Brouwers A, Horn D. Mutations in the prostaglandin transporter encoding gene SLCO2A1 cause primary hypertrophic osteoarthropathy and isolated digital clubbing. Hum Mutat. 2012;33:660–664. https://doi.org/10.1002/humu.22042.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang Z, Xia W, He J et al. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Am. J. Hum. Genet.. 2012;90:125–132. https://doi.org/10.1016/j.ajhg.2011.11.019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Diggle CP, Parry DA, Logan CV et al. Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis. Hum Mutat. 2012;33:1175–1181. https://doi.org/10.1002/humu.22111.

    Article  CAS  PubMed  Google Scholar 

  12. Umeno J, Esaki M, Hirano A et al. Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease. J. Gastroenterol.. 2018. https://doi.org/10.1007/s00535-017-1426-y.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13. Brooke MA, Longhurst HJ, Plagnol V et al. Cryptogenic multifocal ulcerating stenosing enteritis associated with homozygous deletion mutations in cytosolic phospholipase A2-alpha. Gut. 2014;63:96-104. doi:10.1136/gutjnl-2012-303581.

    Article  CAS  PubMed  Google Scholar 

  14. Tay A, Simon JS, Squire J, Hamel K, Jacob HJ, Skorecki K. Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers. Genomics. 1995;26:138–141.

    Article  CAS  Google Scholar 

  15. Sun X, Hosoe N, Miyanaga R et al. A male Korean who was diagnosed with chronic enteropathy associated with SLCO2A1 (CEAS): case report with literature review. BMJ Open Gastroenterol. 2018;5:e000223. https://doi.org/10.1136/bmjgast-2018-000223.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hu P, He H, Dai N, Zhang S, Deng L. Chronic enteropathy associated with SLCO2A1 gene: A case report and literature review. Clin. Res. Hepatol. Gastroenterol.. 2019. https://doi.org/10.1016/j.clinre.2019.05.003

    Article  PubMed  Google Scholar 

  17. Wang Q, Li YH, Lin GL et al. Primary hypertrophic osteoarthropathy related gastrointestinal complication has distinctive clinical and pathological characteristics: two cases report and review of the literature. Orphanet J Rare Dis. 2019;14:297. https://doi.org/10.1186/s13023-019-1264-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Singh A. Cryptogenic Multifocal Ulcerating Stenosing Enteropathy(CMUSE) and/or Chronic Non-specific Multiple Ulcers of the Small Intestine(CNSU) and Non-granulomatous Ulcerating Jejunoileitis (NGUJI). Curr Gastroenterol Rep. 2019;21:53. https://doi.org/10.1007/s11894-019-0721-6.

    Article  PubMed  Google Scholar 

  19. Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424. https://doi.org/10.1038/gim.2015.30.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Huang H, Wang Y, Cao Y et al. Interleukin-6, tumor necrosis factor-alpha and receptor activator of nuclear factor kappa ligand are elevated in hypertrophic gastric mucosa of pachydermoperiostosis. Sci Rep. 2017;7:9686. https://doi.org/10.1038/s41598-017-09671-7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Li SS, He JW, Fu WZ, Liu YJ, Hu YQ, Zhang ZL. Clinical, biochemical, and genetic features of 41 Han Chinese families with primary hypertrophic osteoarthropathy, and their therapeutic response to etoricoxib: results from a six-month prospective clinical intervention. J Bone Miner Res. 2017;32:1659–1666. https://doi.org/10.1002/jbmr.3157.

    Article  CAS  PubMed  Google Scholar 

  22. Oba MS, Murakami Y, Nishiwaki Y et al. Estimated prevalence of Cronkhite-Canada Syndrome, Chronic Enteropathy Associated with SLCO2A1 Gene, and Intestinal Behçet's Disease in Japan in 2017: a nationwide survey. J Epidemiol. 2020. https://doi.org/10.2188/jea.JE20190349.

    Article  Google Scholar 

  23. Perlemuter G, Guillevin L, Legman P, Weiss L, Couturier D, Chaussade S. Cryptogenetic multifocal ulcerous stenosing enteritis: an atypical type of vasculitis or a disease mimicking vasculitis. Gastroenterology. 2001;48(3):333–338. https://doi.org/10.1136/gut.48.3.333.

    Article  CAS  Google Scholar 

  24. Zhang Y, Huang L, Liu R et al. Case report of a pair of siblings with cryptogenic multifocal ulcerating stenosing enteritis: A rare disease easily to be misdiagnosed as Crohn disease. Medicine. 2017;96:e7527. https://doi.org/10.1097/md.0000000000007527.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Yanai S, Yamaguchi S, Nakamura S et al. Immunohistochemical distinction of chronic enteropathy associated with SLCO2A1 from Crohn's disease. Inflamm Bowel Dis. 2017;23:S63.

    Google Scholar 

  26. Yamaguchi S, Yanai S, Nakamura S et al. Immunohistochemistry differentiation between chronic enteropathy associated with SLCO2A1 and other inflammatory bowel diseases. J Gastroenterol hepatol. 2016;31:123.

    Article  Google Scholar 

  27. Matsuno Y, Umeno J, Esaki M et al. Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations. World journal of gastroenterology. 2019;25:1753–1763. https://doi.org/10.3748/wjg.v25.i14.1753.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gomez I, Foudi N, Longrois D, Norel X. The role of prostaglandin E2 in human vascular inflammation. Prostaglandins Leukot Essent Fatty Acids. 2013;89:55–63. https://doi.org/10.1016/j.plefa.2013.04.004.

    Article  CAS  Google Scholar 

  29. Omori K, Kida T, Hori M, Ozaki H, Murata T. Multiple roles of the PGE2 -EP receptor signal in vascular permeability. Br J Pharmacol. 2014;171:4879–4889. https://doi.org/10.1111/bph.12815.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We thank the patients and their families for participating in this study. We also thank Drs. Zhenlin Zhang and Yang Xu for measuring the urinary PGE2 and PGE-M levels of patients for us.

Funding

This study was supported by the National Natural Science Foundation of China (Grant No. 81741057).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yongjun Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

This study was approved by the Ethics Committee of The Second Xiangya Hospital of Central South University and all methods were in accordance with the Declaration of Helsinki. All participants provided written informed consent forms to genetic and biochemical analysis and to publication of all identifying images.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 795 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, H., Wang, X., Ou, D. et al. Four Variants of SLCO2A1 Identified in Three Chinese Patients with Chronic Enteropathy Associated with the SLCO2A1 Gene. Dig Dis Sci 66, 2992–3001 (2021). https://doi.org/10.1007/s10620-020-06629-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06629-0

Keywords

Navigation